CMC and Investment
Where Capital Meets CMC: The Emerging Role of CDMOs in Investor Risk Assessment
David Alvaro, Ph.D.; Daniel Smith, Ph.D.
Pharma's Almanac
PAO-01-26-NI-15Jan 15, 2026
Risk Sharing
Risk-Sharing Rewritten: How Biopharma Partnerships Are Redesigning Incentives Beyond the Deal
David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-26-NI-05Jan 9, 2026
Partnerships
Structured Deals on the Rise: Milestones, Options, and Risk-Sharing in Biopharma Licensing
David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-26-NI-04Jan 8, 2026